The reason for the sharp fall in the stock couldn’t be ascertained at the time of filing this report. However, the private sector lender has been struggling with rising bad loans at a time when most of its peers, including the public sector ones, have shown sharp improvement in asset quality.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,